Biomillenia’s innovative skincare product development pipeline was rewarded with the maximum amount of non-dilutive funding from the Innov’up Leader PIA program by BPIFrance Financement. We are proud to have been selected as a winner of this product development grant that will support the creation of novel skincare solutions that act through modulation of the microbiota of the human skin and scalp. Sensitive and inflammatory skin conditions often go along with accelerated growth of certain microbial species and a breach of the skin barrier function. Biomillenia’s product development aims at providing a balanced skin microbiota that can contribute to an overall lower inflammatory activity and more robust skin barrier function.
